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doi:10.1016/j.ejvs.2010.01.013Abstract Objective: Telomeres are specialised DNA structures present at the ends of linear
chromosomes, which shorten with each successive cell division and the length of which repre-
sents cellular biological age. The aim of this study was to determine the relationship between
abdominal aortic aneurysm (AAA) and white cell telomere length.
Methods: Peripheral blood samples were collected from 190 patients with AAA and 183
controls. Genomic DNA was extracted from white cells and telomere lengths determined using
a chemiluminescence technique.
Results: The mean white cell telomere length was significantly lower in AAA patients
compared to controls (median age 66 years in both groups), with a mean difference of 189 base
pairs (bp) (95% confidence interval 77 bp to 301 bp, PZ 0.005). This relationship between
caseecontrol status and mean telomere restriction fragment (TRF) length did not change after
adding other risk factors into a multiple regression model. The risk of having AAA doubled in
patients with a mean TRF length in the lowest quartile compared to patients with a mean
TRF length in the highest quartile (odds ratio 2.30, 95% Confidence Interval 1.28e4.13,
PZ 0.005).
Conclusion: Our data show that patients with AAA have shorter leukocyte telomere length
compared to controls. This suggests that vascular biological aging may have a role in the path-
ogenesis of AAA.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Telomeres are specialised DNA (deoxyribonucleic acid)
structures present at the ends of linear chromosomes. They3 9086582; fax: þ44 116 2523179
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ty for Vascular Surgery. Publisheare made up of a string of TTAGGG repeats and protect the
chromosome ends from enzymatic degradation, recon-
struction, fusion and loss.1 With each cell division, inevi-
table loss of telomeric DNA occurs due to an ‘end.
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560 G. Atturu et al.replication problem’, where a few bases at the 30 end of
each template are not copied during DNA replication. Germ
cells and some somatic cells produce an enzyme called
telomerase that can add TTAGGG repeats and prevent
telomere attrition. The difference between initial telomere
length and telomere length at any given time thereafter
predicts the biological age of the cell, hence telomeres can
be considered as a mitotic clock.2 Human telomere length is
genetically determined3e6 and is influenced by environ-
mental factors such as oxidative stress7 and smoking.8
Within an individual there is a high similarity in telomere
length between various tissues9e11 and leukocyte telomere
length is commonly used as a surrogate marker for overall
telomere length.
Vascular tissue is constantly exposed to mechanical and
haemodynamic insults and a healthy endothelial layer is
essential to withstand this repetitive stress. Damaged and
dysfunctional endothelial cells are constantly replaced by
surrounding endothelial cells and endothelial progenitor
cells. Arteries exposed to high haemodynamic disturbances
show increased endothelial cell turnover and consequent
telomere shortening.12 Iliac artery endothelial cells have
shorter telomere lengths than endothelial cells from iliac
veins and the internal thoracic artery.13 The intima and
media of the distal abdominal aorta demonstrates
increased telomere attrition compared to the proximal
abdominal aorta.14
In addition to local vascular telomere attrition, the
telomere length of circulating white cells is also decreased
in patients with cardiovascular diseases. Patients with
coronary atherosclerosis,15 premature myocardial infarc-
tion,16 congestive cardiac failure17 and aortic stenosis18
have shorter leukocyte telomere lengths compared to
healthy controls. Wilson10 found significant reduction in
telomere content of abdominal aortic aneurysm (AAA) wall
samples compared to normal aorta. The aim of this study
was to determine the association between white cell telo-
mere length and abdominal aortic aneurysm.
Methods
Subjects and tissue samples
One hundred and ninety patients with infrarenal AAA from
the Leicester vascular unit were recruited together with
183 age-matched controls. All consecutive patients
attending the out-patient clinics with aortic diameters
greater than 30 mm were invited to participate in the
study. The only exclusion criterion was an inability or
refusal to consent to participate in the study. Subjects were
considered to have AAA when the maximum external
diameter of the infrarenal abdominal aorta was equal to or
more than 30 mm, measured using ultrasound scan or CT
scan. All controls were screened by either ultrasound or CT
scan to exclude the presence of AAA and the same exclu-
sion criteria applied as per the AAA group. Control partic-
ipants were recruited from the regional AAA screening
programme and the same out-patient clinics as the partic-
ipants with AAA. The presence or absence of risk factors
including smoking (current, ex-smoker or non smoker),
hypertension and diabetes (type I or type II) were self-reported by the subjects. Positive family history was
defined as having a minimum of one first degree relative
with AAA. Fifteen to twenty millilitres of blood was
collected from the antecubital vein and separated into
plasma and white cells (buffy coat). The buffy coat was
snap frozen and stored at 80 C for future batch analysis.
The study was approved by the local NHS Research Ethics
Committee.
Telomere length assay
DNA was extracted from the buffy coat using a Puregene
DNA extraction kit (Flowgen Bioscience Ltd, United
Kingdom). The mean terminal restriction fragment (TRF)
length, a marker of telomere length, was measured by
a chemiluminesence technique using teloTAGGG telomere
length assay kits (Roche-Applied Science, Germany). In
brief, 25 ml of each DNA sample (75 ng/ml) was digested
with 10 U of Rsa I (Invitrogen Ltd, UK) and 10 U of Hinf I
(Invitrogen Ltd, UK) at 37 C for two and half hours. The
DNA fragments were separated by electrophoresis on 0.6%
agarose gels (20 20 cm) at 150 V for 1 h and 50 V for 18 h.
The DNA was then depurinated with 0.25% HCl for 20 min,
denatured with 0.5 mol/L NaOH/1.5 mol/L NaCl for 30 min
and neutralized with 0.5 mol/L Tris/1.5 mol/L NaCl, pH 8
for 30 min. The DNA was transferred overnight on to
a positively charged nylon membrane (Amersham Hybon
Nþ, GE Healthcare, UK) using a southern blot technique and
fixed with ultraviolet light. The membrane was then
hybridized with a telomere repeat specific digoxigen (DIG)
labelled probe overnight at 42 C. The membrane was
washed three times with 2 SSC (saline sodium citrate)/
0.1% SDS (sodium dodecyl sulphate) followed by 0.2 SSC/
0.1% SDS. The membrane was then incubated with a DIG
specific antibody covalently coupled to alkaline phospha-
tase. The immobilised telomere probe was then visualised
using CDP star, a highly chemiluminescent substrate for
alkaline phosphate. Exposing the membrane to an autora-
diograph film (Amersham Hyperfilm ECL, GE Healthcare,
UK) revealed the telomere smears. The mean terminal
restriction fragment of each sample was calculated using
the formula mean TRFZ TRFZðP ðODiÞÞ=ð
PðODi=LiÞÞ,
where ODi is the optical density at a given position on the
gel and Li is the molecular weight at that position. An
internal control with a known mean TRF length (DNA
extracted from HUVEC cells) was used to study the inter-gel
and intra-gel variation in mean TRF length (data not
shown). The mean TRF length of samples from cases and
controls were adjusted to the standardised internal control
to account for the inter-gel and intra-gel variation (Fig. 1).
Statistical analysis
All statistical analysis was performed using SPSS version
16.0 (SPSS Inc. Chicago). Demographic characteristics of
cases and controls were compared using chi square test for
categorical variables and an independent samples ‘t’ test
for continuous variables. The difference in mean TRF length
between cases and controls was analysed using an inde-
pendent samples ‘t’ test. The difference in mean TRF
length in subjects with different risk factors was analysed
Figure 1 An autoradiogram showing the telomere smears of
leukocyte DNA from cases and controls. Each sample is labelled
by caseecontrol status, gender and age. At the both ends
molecular weight markers were run to calculate the mean TRF
length. In this gel a mixture of 20 cases and controls were run
on the left hand side and one internal control on the right hand
side.
Table 1 Demographics of cases and controls.
Cases Controls P
(nZ 190) (nZ 183)
Mean age (SD) 69.47 (6.66) 68.98 (6.2) 0.46
Male gender 176 (93%) 171(93%) 0.75
Current or ex-smokers (%) 179 (94%) 131 (72%) <0.0001
Hypertension (%) 105 (55%) 87(47%) 0.15
Diabetes (type I/type II) 23 (12%) 29 (16%) 0.27
Positive history
of MI (%)
60 (32%) 39 (21%) 0.02
Positive family
history of AAAa
19 (10%) 12 (7%) 0.14
Aneurysm size
in centimetres (cm)
5.15 (1.57) NA e
Data are shown as percentages for categorical variables and
means (standard deviation) for continuous variables.
Abbreviations: SD e standard deviation, NA e not applicable,
MI e Myocardial Infarction, AAA e Abdominal Aortic Aneurysm,
cm e centimetre.
a Family history was not reported in 18 patients.
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independent samples ‘t’ test for categorical variable. The
independent effect of age, sex and other risk factors on the
mean TRF length was analysed using a linear regression
model controlling for case control status. Those demo-
graphic variables found to be associated with AAA on
univariate analysis were entered into a binary logistic
regression model using a forward entry method together
with mean leukocyte TRF length to determine whether any
association seen between AAA and telomere length was
independent of other covariates. Only covariates found to
be significantly associated with AAA were retained in the
final model.
Results
One hundred and ninety patients with infrarenal AAA
(median age 66 years, range 56e91 years) were recruited
together with 183 age-matched controls (median age 66
years, range 57e87 years). The mean aneurysm size was
5.15 cm (range 3e10 cm). The demographic characteristics
of patients with AAA and controls are shown in Table 1.
The mean TRF length in the AAA group (5.550, standard
deviation (SD)Z 0.605 kbp), was significantly lower than
that observed in the control group (5.739, SDZ 0.485 kbp).
There was a mean difference of 189 bp between AAA andcontrols (95% Confidence Interval 77 bp to 301 bp,
PZ 0.001). There was no significant change in the mean
TRF length with age in both AAA and controls (6 bp increase
per year, SDZ 4; PZ 0.16). There was also no significant
correlation between aneurysm size and mean TRF length
(PZ 0.35). There was no significant difference in the mean
TRF length between male and female subjects.
The difference in mean TRF length between subjects
based on risk factors such as gender, smoking, hyperten-
sion, diabetes, history of MI and family history of AAA is
shown in Table 2. Sex as an independent risk factor did not
have any significant effect on the mean TRF length
(PZ 0.99). Positive family history of AAA was the only risk
factor which was significantly associated with the mean TRF
length (PZ 0.04). Subjects with a positive family history of
AAA had a significantly shorter mean TRF length (5.491,
SDZ 0.485) compared to subjects without a family history
of AAA (5.684, SDZ 0.502), (mean difference 192 bp,
Confidence interval 7 bp to 378 bp, PZ 0.02). Entering all
these risk factors into a multiple regression model did not
affect the relationship between AAAecontrol status and
mean TRF length (PZ 0.01). The impact of each risk factor
on the mean TRF length was estimated individually using
a linear regression model after controlling for AAAecontrol
status (Table 3).
The effect of telomere length as a risk factor for AAA is
shown in Table 4. With each kilo base pair decrease in mean
TRF length the odds ratio for AAA was 1.99 (95% Confidence
interval, 1.31e3.00, PZ 0.001). Compared with those in
the highest quartile for mean TRF length, people in the
lowest, second and third quartiles had an odds ratio of 2.30
(95% Confidence interval, 1.28e4.13, PZ 0.005), 1.42 (95%
Confidence interval, 0.80e2.52, PZ 0.22), 1.07 (95%
Confidence interval, 0.60e1.91, PZ 0.80) respectively.
Discussion
In this study we have shown that patients with AAA have
significantly shorter mean white cell TRF length compared
Table 2 Mean (standard deviation) telomere restriction fragment length and the difference in telomere lengths between
subjects based on risk factors (Students t-test).
Risk Factor Mean TRF length (kbp) in subjects Mean difference 95% Confidence interval P
Absent Present
Male gender 5.64 (0.85) 5.64 (0.53) 0.00 0.22 to 0.22 0.99
Positive smoking
history (ever/current)
5.68 (0.62) 5.63 (0.54) 0.05 0.10 to 0.20 0.51
Hypertension 5.67 (0.54) 5.61 (0.57) 0.06 0.05 to 0.18 0.26
Diabetes mellitus
(type I/type II)
5.66 (0.57) 5.55 (0.45) 0.11 0.05 to 0.28 0.18
History of MI 5.67 (0.54) 5.55 (0.60) 0.12 0.01 to 0.25 0.06
Family history of AAA 5.68 (0.50) 5.49 (0.49) 0.19 0.01 to 0.38 0.04
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AAA and controls was not affected by other confounding
factors such as smoking, hypertension and diabetes. In our
study the risk of having AAA doubled in patients with
mean leukocyte TRF length in the lowest quartile
compared to patients with mean TRF length in the highest
quartile.
Relatively large numbers of subjects were recruited in
this study and all the subjects were well matched for age
and gender. AAA is a well-defined phenotype and hence we
did not find difficulty in identifying patients with AAA. We
have used the International Society of Cardiovascular
Surgery (ISCS)/Society for Vascular Surgery (SVS) defini-
tion19 to identify patients with AAA. The age of our subjects
ranged from 56 years to 91 years as the incidence of AAA in
adults is rare below 50 years of age and the prevalence
increases steadily thereafter.20 We have measured telo-
mere length using terminal restriction fragment assay
(southern blot technique) rather than the recently devel-
oped assays like polymerase chain reaction or quantitative
hybridization.21 Although the terminal restriction fragment
assay is time consuming and laborious it measures the
telomere length directly rather than measuring the telo-
mere content.
Previous studies have shown that human leukocytes
undergo age dependent telomere attrition.16,22e24 In spite
of the wide range in the age group of subjects in this studyTable 3 Effects of risk factors on mean TRF length
(Standard Deviation) after adjusting for caseecontrol status
(P-values taken from linear regression model).
Variable Effect on mean
TRF length (bp)
P
Age (change per year) 6 (4) 0.16
Male gender 7 (112) 0.94
Smoking 28 (80) 0.72
Hypertension 50 (57) 0.37
Diabetes (type I or type II) 126 (82) 0.12
Myocardial infarction 99 (65) 0.12
Family history of AAA 174 (94) 0.06
Aneurysm Size (cases only) 29 (31) 0.35
Negative values indicate that the telomere length was shorter
in subjects with this risk factor.we did not find any significant decrease in mean TRF length
with age in either group. In contrast we found an increase
in telomere length by 6 bp per year, although this did not
have statistical significance. Similarly, Martin-Ruiz25 did not
find significant changes in mean leukocyte telomere length
with aging in subjects older than 85 years and Mukherjee26
did not find any correlation between subjects’ age and
leukocyte telomere length in coronary patients of Indian
origin.
The exact effect of gender on telomere length and its
attrition rate is not clear. Some studies5,27e29 found that
females have longer telomeres than males whereas
others16,17,30,31 did not find a difference. Age dependent
telomere attrition was found to be higher in males
compared to females and the difference disappeared in
postmenopausal women.32 The possible role of estrogens on
telomerase and their anti-oxidant effect could contribute
to the slower telomere attrition rate in pre-menopausal
women.33 In our study female subjects were all post-
menopausal. Other risk factors such as hypertension, dia-
betes and a positive history of MI, although having a nega-
tive trend did not have a statistically significant association
with mean TRF length.
The association of shortened telomeres with AAA is
biologically plausible. Telomere shortening is classically
thought to be due to increased cellular turnover e which
occurs at an increased rate in the distal aorta compared to
other tissues14 and telomere length can thus be seen to be
directly related to cellular aging. However, in addition
oxidative stress can directly cause telomere shortening34
and whilst there is some evidence for the role of pathways
that modulate oxidative stress in the pathogenesis of AAA in
both animal and human studies.35e37 Several descriptive
transcriptomic studies38e40 have not consistently demon-
strated a role for oxidative stress in AAA. In fact, the most
consistent finding across these studies is a role for immune
function in the pathogenesis of AAA e which has not been
examined in relation to telomere length in AAA but asso-
ciations between decreasing immune function and short-
ened telomere lengths have been observed in human
populations.41,42
Several limitations of our study need to be considered.
Telomere length varies between different chromosomes
and cells types.43 Mean TRF length is a crude way of
measuring cellular telomere attrition. Critical shortening
in the telomere length can occur in one chromosome
Table 4 Results of binary logistic regression modelling. Only variables found to be significantly associated with AAA were
retained in the model. Risk factors shown are for the presence of AAA.
Beta Standard error P Odds ratio 95% Confidence interval
Smoking 2.00 0.37 <0.0001 7.39 3.57e15.27
Telomere length 0.68 0.21 0.001 1.99 1.31e3.00
Constant 4.20 1.20 <0.0001 0.02 e
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identifying individual chromosomal telomere length vari-
ations will help in understanding the effect of such changes
on cellular function and disease. Such studies may provide
an insight into the common association of cardiovascular
diseases with shorter telomere length and identify culprit
chromosomes. Haematological malignancies have been
shown to be associated with leucocyte telomere
length.44,45 Whilst we did not screen our patients for the
presence of haematological malignancy no patients
reported having any such disease and this missing data is
therefore unlikely to have significantly altered the results
from this study. In a similar fashion every single co-
morbidity suffered by each participant was not recorded.
Previous myocardial infarction was used as a surrogate
measure of coronary artery disease but no further assess-
ment of systemic atherosclerosis was made (for example
ankle-brachial pressure-index or history of cerebrovascular
disease). We believe that the addition of multiple further
covariates to our model would in all likelihood have resul-
ted in a high chance of a type I error and, in a study of
a relatively small size such as this, the minimal covariate
dataset used is appropriate.
We have not examined the correlation between leuko-
cyte telomere length and aortic wall biopsy telomere
length. Although Wilson10 found a correlation, the sample
size was small (20 AAA and 12 controls) and the results need
to be confirmed in larger studies. In this caseecontrol
study, we cannot completely exclude the possibility that an
unmeasured factor accounts for the observed relationship.
A prospective longitudinal study will help in identifying the
true changes in mean TRF length with age and its role in the
pathogenesis of AAA. Such a prospective study will also help
in identifying the possible prognostic value of leucocyte
telomere length on the rate of aneurysm expansion,
rupture and overall mortality.
No evaluation of telomere lengths in patients with
ruptured AAA was made in this study. This data may add
further information to confirm or refute the association seen
in this data on intact AAA. It would be expected that
patients with ruptured AAA would have even shorter telo-
mere lengths than those with intact AAA if telomere length
was associated not only with AAA but progression of AAA.
Patients with ruptured AAA may exhibit an acute inflam-
matory response with a higher proportion of circulating
leucocytes being activated rendering their DNA at risk of
degradation. This would potentially affect the telomere
assay in circulating leucocytes and in these patients a better
choice of tissue to compare may be aortic wall specimens.
No data exists in the literature examining this hypothesis.
In summary, we report a significant association between
shorter leukocyte telomere length and the risk of AAA. The
mean leukocyte TRF length of patients with AAA issignificantly shorter compared to controls. This suggests
that vascular biological aging may have a role in the path-
ogenesis of AAA.
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